Myelin Basic Protein Antibodies

Measures IgG and IgA antibodies against different tissue antigens that are found from head to toe. These tissues are involved in more than 90 different autoimmune diseases. Detection of antibodies against these antigens at the early stage helps in the prevention and management of many autoimmune disorders since these predictive antibodies can be detected 3-19 years before the development of the clinical stage of an autoimmune disease. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2008, 2020, 2021, 2023, and 2024.

Measures total and specific salivary IgA against 25 different antigens that are major components of the GI tract or are introduced into it. Detects the overall integrity of the mucosal immune system, also known as our body’s first line of defense. It also detects early events associated with broken oral tolerance to many external and internal factors that are involved in the induction of leaky gut, food and chemical immune reactivity, and autoimmunity. It detects early signs and signals of autoimmunities before their appearance in the blood. Developed, published, and patented by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology in 2004 and 2007.

Measures IgG, IgA, and IgM antibodies against five major neuron-specific antigens: myelin basic protein, asialoganglioside, alpha + beta tubulin, cerebellar, and synapsin. These antibodies are detected in patients with a variety of neuroimmune disorders, chronic fatigue/fibromyalgia, viral infections including SARS-CoV-2, EBV, CMV, HHV-6, long COVID, autism, ADD/ADHD, neuropsychiatric disorders, and exposure to toxic chemicals and molds and mycotoxins. Developed, patented, and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2005, 2007, 2008, 2020, and 2023.

Measures IgG and IgA antibodies against different tissue antigens that are found from head to toe. These tissues are involved in more than 90 different autoimmune diseases. Detection of antibodies against these antigens at the early stage helps in the prevention and management of many autoimmune disorders since these predictive antibodies can be detected 3-19 years before the development of the clinical stage of an autoimmune disease. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2008, 2020, 2021, 2023, and 2024.